Adial Pharmaceuticals Files Proxy Statement for Annual Meeting
Ticker: ADIL · Form: DEF 14A · Filed: Sep 27, 2024 · CIK: 1513525
| Field | Detail |
|---|---|
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
| Form Type | DEF 14A |
| Filed Date | Sep 27, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Adial Pharma proxy filed - shareholders vote Nov 12 on directors & auditors.
AI Summary
Adial Pharmaceuticals, Inc. filed a DEF 14A proxy statement on September 27, 2024, for its annual meeting on November 12, 2024. The filing details the company's governance and proposals to be voted on by shareholders, including the election of directors and ratification of its independent registered public accounting firm.
Why It Matters
This filing provides shareholders with crucial information to make informed decisions on company leadership and important corporate matters at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating new financial risks or significant operational changes.
Key Players & Entities
- ADIAL PHARMACEUTICALS, INC. (company) — Registrant
- 0001213900-24-082805.txt (document) — Filing identifier
- 20240927 (date) — Filing date
- 20241112 (date) — Annual meeting date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders of Adial Pharmaceuticals, Inc. with information regarding the company's annual meeting of shareholders, including proposals to be voted upon, such as the election of directors and the ratification of the independent registered public accounting firm.
When is the annual meeting of shareholders scheduled to take place?
The annual meeting of shareholders is scheduled to take place on November 12, 2024.
Who is the registrant filing this proxy statement?
The registrant filing this proxy statement is ADIAL PHARMACEUTICALS, INC.
What is the filing date of this DEF 14A document?
This DEF 14A document was filed on September 27, 2024.
What are some of the key items shareholders will vote on?
Shareholders will vote on proposals including the election of directors and the ratification of the company's independent registered public accounting firm.
Filing Stats: 4,376 words · 18 min read · ~15 pages · Grade level 15.7 · Accepted 2024-09-27 17:20:46
Key Financial Figures
- $0.001 — s to holders of shares of common stock, $0.001 par value per share, of Adial Pharmaceu
Filing Documents
- ea0212489-01.htm (DEF 14A) — 1391KB
- tadial_logo.jpg (GRAPHIC) — 112KB
- tbarchart_001.jpg (GRAPHIC) — 349KB
- tbarchart_002.jpg (GRAPHIC) — 352KB
- tproxy_001.jpg (GRAPHIC) — 1376KB
- tproxy_002.jpg (GRAPHIC) — 1212KB
- 0001213900-24-082805.txt ( ) — 6078KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION   31 PAY VERSUS PERFORMANCE   37 OTHER INFORMATION REGARDING THE COMPANY   41 TRANSACTIONS WITH RELATED PERSONS, PROMOTERS AND CERTAIN CONTROL PERSONS   43 OTHER MATTERS   46 ANNUAL REPORT/FORM 10-K   46 NOTICE REGARDING DELIVERY OF STOCKHOLDER DOCUMENTS (“HOUSEHOLDING” INFORMATION)   46 STOCKHOLDER PROPOSALS FOR THE 2025 ANNUAL MEETING   47 APPENDIX A   A-1 i Table of Contents 4870 Sadler Road, Suite 300 Glen Allen, Virginia 23060 PROXY STATEMENT For the Annual Meeting of Stockholders to be held on November 12 , 2024 GENERAL INFORMATION We are providing these proxy materials to holders of shares of common stock, $0.001 par value per share, of Adial Pharmaceuticals, Inc., a Delaware corporation (referred to as “Adial,” the “Company,” “we,” or “us”), in connection with the solicitation by the Board of Directors (the “Board” or “Board of Directors”) of Adial of proxies to be voted at our 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting” or the “Annual Meeting”) to be held on November 12, 2024, beginning at 8:30 a.m., local time at 675 Peter Jefferson Parkway, Suite 160, Charlottesville, VA 22911, and at any adjournment or postponement of our 2024 Annual Meeting. The purpose of the 2024 Annual Meeting and the matters to be acted on are stated in the accompanying Notice of Annual Meeting. The Board of Directors knows of no other business that will come before the 2024 Annual Meeting. Our Board of Directors is soliciting votes (1)  FOR each of the two (2) nominees for Class III directors named herein for election to our Board of Directors; (2)  FOR the ratification of the appointment of Marcum LLP (“Marcum”) as our independent registered p